세계의 감염 감시 솔루션 시장 : 제품, 전개, 최종 사용자별 예측(2025-2030년)

The Infection Surveillance Solution Market was valued at USD 768.47 million in 2023, expected to reach USD 867.99 million in 2024, and is projected to grow at a CAGR of 13.36%, to USD 1,849.73 million by 2030.

Infection Surveillance Solutions (ISS) involve comprehensive systems and methodologies designed to monitor, prevent, and manage infections, especially within healthcare settings. These solutions encompass software platforms, analytical tools, and real-time data monitoring systems. Their necessity stems from the urgent need to curtail healthcare-associated infections (HAIs), optimize antibiotic use, and enhance patient safety, which are critical due to increasing drug-resistant pathogens and nosocomial infections. Application areas include hospitals, outpatient facilities, and assisted living environments, serving as instrumental tools for infection prevention teams, epidemiologists, and healthcare administrators. The market for ISS is primarily driven by heightened awareness around HAIs, government mandates for infection control, and the continuous evolution of healthcare infrastructure, particularly in developed regions. Additionally, technological advancements such as machine learning and AI in data analytics offer potential opportunities by enabling more predictive and personalized infection control measures. However, limitations like high initial costs, integration complexities with existing hospital information systems, and data privacy concerns pose significant challenges. Further, a lack of awareness and inadequate infrastructure in developing regions hinder market penetration and growth. The best opportunity for innovation lies in developing interoperable platforms that can seamlessly integrate with diverse health IT systems, adopting AI-enabled predictive analytics for early infection warning, and harnessing wearable technology for real-time patient monitoring. The market is largely technology-driven, with a dynamic focus on digital transformation in healthcare. Thus, businesses aiming for growth should invest in R&D that enhances system interoperability and user interface design, ensuring compliance with data protection regulations. Given the increasing global health concerns, such strategic moves could position a company as a leader in infection prevention technology, driving market evolution and public health improvements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infection Surveillance Solution Market

The Infection Surveillance Solution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing geriatric population coupled with increasing incidences of chronic diseases
  • Increasing prevalence of hospital-acquired infections (HAIs)
  • Rising adoption of antimicrobial stewardship programs
• Market Restraints
  • High cost associated with the deployment of infection surveillance solutions
• Market Opportunities
  • Development of fully automated infection surveillance solution systems with the integration of electronic medical records
  • Rapid emergence of cloud based infection surveillance solutions
• Market Challenges
  • Limited availability of skilled healthcare IT professional

Porter's Five Forces: A Strategic Tool for Navigating the Infection Surveillance Solution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infection Surveillance Solution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infection Surveillance Solution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infection Surveillance Solution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infection Surveillance Solution Market

A detailed market share analysis in the Infection Surveillance Solution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infection Surveillance Solution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infection Surveillance Solution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infection Surveillance Solution Market

A strategic analysis of the Infection Surveillance Solution Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Surveillance Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Altarum, Baxter International, Inc., Becton, Dickinson and Company, bioMerieux SA, BioVigil Healthcare Systems, Inc., Cardinal Health Inc., CenTrak, Inc., Clinsys, Inc., Conduent, Inc., Datlowe, s.r.o., DNV AS, Ecolab Inc., Gunnebo Entrance Control Ltd., Health Matrix., Ibhar Technologies Pvt Ltd, Inovalon, International Business Machines Corporation, Medexter Healthcare GmbH, Oracle Corporation, PointClickCare, Premier Inc., RLDatix, Securitas Healthcare, LLC., Strategic Solutions Group, Thermo Fisher Scientific Inc., Vecna Technologies, Inc., VigiLanz Corporation, Vitalacy Inc., Vizzia Technologies, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Infection Surveillance Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Services and Software. The Services is further studied across Implementation Services, Product Support & Maintainnace Services, and Training & Consulting Services. The Software is further studied across Antimicrobial Monitoring & Control, Infection Surveillance, Outbreak Management, and Staff Health & Compliance. The Infection Surveillance is further studied across Laboratory surveillance and Surgical surveillance & patient monitoring. The Outbreak Management is further studied across Isolation Management and Potential Outbreak Alert.
• Based on Deployment, market is studied across On-Cloud and On-Premise.
• Based on End-User, market is studied across Hospital, Laboratories, and Long-Term Care Facility.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing geriatric population coupled with increasing incidences of chronic diseases
    • 5.1.1.2. Increasing prevalence of hospital-acquired infections (HAIs)
    • 5.1.1.3. Rising adoption of antimicrobial stewardship programs
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the deployment of infection surveillance solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of fully automated infection surveillance solution systems with the integration of electronic medical records
    • 5.1.3.2. Rapid emergence of cloud based infection surveillance solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of skilled healthcare IT professional
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Infection Surveillance Solution Market, by Product

• 6.1. Introduction
• 6.2. Services
  • 6.2.1. Implementation Services
  • 6.2.2. Product Support & Maintainnace Services
  • 6.2.3. Training & Consulting Services
• 6.3. Software
  • 6.3.1. Antimicrobial Monitoring & Control
  • 6.3.2. Infection Surveillance
    • 6.3.2.1. Laboratory surveillance
    • 6.3.2.2. Surgical surveillance & patient monitoring
  • 6.3.3. Outbreak Management
    • 6.3.3.1. Isolation Management
    • 6.3.3.2. Potential Outbreak Alert
  • 6.3.4. Staff Health & Compliance

7. Infection Surveillance Solution Market, by Deployment

• 7.1. Introduction
• 7.2. On-Cloud
• 7.3. On-Premise

8. Infection Surveillance Solution Market, by End-User

• 8.1. Introduction
• 8.2. Hospital
• 8.3. Laboratories
• 8.4. Long-Term Care Facility

9. Americas Infection Surveillance Solution Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Infection Surveillance Solution Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Infection Surveillance Solution Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Orbis Protect Acquires Secure Site UK to Further Enhance Their Security Solutions & Service Offering.
  • 12.3.2. West Hartford-Bloomfield Health District Coalition Against Healthcare-Acquired Infections Team Recognized as NACCHO Infection Prevention and Control Champion.
  • 12.3.3. American Firm Named as Sole Supplier For £20m (USD 24.06 Million) Framework.
  • 12.3.4. Foresight Group Invests Additional £1 Million (USD 1.20 Million) from the Midlands Engine Investment Fund into ReadyGo Diagnostics Limited.
  • 12.3.5. RACGP Launches New Infection Prevention and Control Guidelines.
  • 12.3.6. MIT Chemists Develop a Wireless Electronic Lateral Flow Assay Test for Biosensing.
  • 12.3.7. Infection Prevention and Control Online Learning Launched.
  • 12.3.8. Premier Brings PINC AI Clinical Surveillance Technology to Long-Term Care Facilities.
  • 12.3.9. Bitscopic's Clinical Surveillance Software to be Implemented at VA Los Angeles and VA Las Vegas.
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Altarum
• 3. Baxter International, Inc.
• 4. Becton, Dickinson and Company
• 5. bioMerieux SA
• 6. BioVigil Healthcare Systems, Inc.
• 7. Cardinal Health Inc.
• 8. CenTrak, Inc.
• 9. Clinsys, Inc.
• 10. Conduent, Inc.
• 11. Datlowe, s.r.o.
• 12. DNV AS
• 13. Ecolab Inc.
• 14. Gunnebo Entrance Control Ltd.
• 15. Health Matrix.
• 16. Ibhar Technologies Pvt Ltd
• 17. Inovalon
• 18. International Business Machines Corporation
• 19. Medexter Healthcare GmbH
• 20. Oracle Corporation
• 21. PointClickCare
• 22. Premier Inc.
• 23. RLDatix
• 24. Securitas Healthcare, LLC.
• 25. Strategic Solutions Group
• 26. Thermo Fisher Scientific Inc.
• 27. Vecna Technologies, Inc.
• 28. VigiLanz Corporation
• 29. Vitalacy Inc.
• 30. Vizzia Technologies
• 31. Wolters Kluwer N.V.